MARKET

HROWL

Harrow Health
HROWL
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-52.2333
4.570
18.94
-
Harrow Inc. Files Initial Beneficial Ownership Statement for Chief Commercial Officer Patrick William Sullivan
Reuters · 5d ago
Harrow Reaffirms 2025 Revenue Guidance of $270–$280 Million
Reuters · 5d ago
HARROW REAFFIRMS 2025 FULL-YEAR REVENUE GUIDANCE OF $270–$280 MILLION, MARKING ANOTHER YEAR OF STRONG GROWTH
Reuters · 5d ago
Opaleye Management Inc. Reports Disposal of Harrow Inc. Common Shares
Reuters · 01/08 21:06
HARROW, INC. <HROW.O>: H.C. WAINWRIGHT RAISES TARGET PRICE TO $69 FROM $64
Reuters · 11/12/2025 11:02
U.S. RESEARCH ROUNDUP-Floor & Decor Holdings, Composecure, Outfront Media
Reuters · 11/12/2025 07:18
Eye care drugmaker Harrow swings to Q3 profit
Reuters · 11/10/2025 21:23
Harrow Inc. reports third-quarter revenue of $71.6 million and net income of $1.0 million
Reuters · 11/10/2025 21:12
More

Webull offers Harrow Health stock information, including NASDAQ: HROWL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROWL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HROWL stock methods without spending real money on the virtual paper trading platform.